Skip to main content
Clinical Trials/CTRI/2024/02/063083
CTRI/2024/02/063083CompletedNot Applicable

Clinical Validation of Smart EYE Endoscopy System

Biotechnology Industry Research Assistance Council (BIRAC)1 site in 1 country30 target enrollmentStarted: March 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Performance Evaluation Metrics - Mechanical, Video Processor, Software & System Stability, Image Quality.

Study Overview

Brief Summary

SmartEYE Ultra is an endoscopy system indigenously designed and developed by Healthcare Technology Innovation Center (HTIC), Indian Institute of Technology (IIT), Madras for Mitra Medical Services LLP, Parwanoo under the National Biopharma Mission (NBM - an Industry-Academia Collaborative Mission of Department of Biotechnology (DBT)) implemented by BIRAC (Biotechnology Research Assistance Council). The endoscopy system has been certified for EMI/EMC compliance by SAMEER CEM, Chennai. The device has also been certified for basic safety compliance under IEC 60601-1 by ITC India Pvt. Ltd., Chandigarh. The device was also taken for Animal Trials at the Palamur Biosciences Pvt. Ltd., Mahabubnagar, Telangana, which issued a report clearing the SE Ultra system for use in gastroscopic evaluations of human subjects in clinical setups.

SmartEYE Ultra endoscopy system needs to be evaluated for its performance in mechanical handling, video processing, software system stability and image quality. For this, the SmartEYE Ultra system will be used in endoscopic procedures on 30 human subjects, during which the gastroenterologists will be asked to evaluate the above metrics based on the proforma for evaluation. The evaluation reports from the gastroenterologists will be used as a proof for clinical trials on humans and based on these reports the SE Ultra system is expected to be cleared for clinical use in hospitals.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Willingness to participate.
  • •Clinical diagnosis of GI tract disorder.
  • •Stable medical conditions.

Exclusion Criteria

  • •Unwillingness to participate.
  • •Patients with cardiovascular and uncontrolled diabetic condition.
  • •Unstable medical condition.
  • •Pregnant women.

Outcomes

Primary Outcomes

Performance Evaluation Metrics - Mechanical, Video Processor, Software & System Stability, Image Quality.

Time Frame: 2 months

For each of the 4 performance metrics, the gastroenterologist will be asked to give a score out of 5, with 5 being the highest. Average of the performance metrics for each category will be computed and used for decision making. An average of above 3.5 out of 5 will be considered as PASS.

Time Frame: 2 months

Secondary Outcomes

  • To obtain feedback and preference about the mBLU modes implemented in the system(2 months)

Investigators

Sponsor
Biotechnology Industry Research Assistance Council (BIRAC)
Sponsor Class
Government funding agency
Responsible Party
Principal Investigator
Principal Investigator

Dr Venkateswaran G

Sri Venkateswaraa Medical College Hospital and Research Institute

Study Sites (1)

Loading locations...

Similar Trials